Literature DB >> 6335865

Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumatica.

G Chelazzi, M Broggini.   

Abstract

The T lymphocyte subsets were studied by monoclonal antibodies in the blood of eight patients with polymyalgia rheumatica. The percentages of circulating T cells (OKT3+) were lower when compared with normal controls (p less than 0.02), as were the proportions of suppressor/cytotoxic (OKT8+) T cells (p less than 0.001), whereas the proportions of helper/inducer (OKT4+) T lymphocytes were not changed. Consequently, the OKT4:OKT8 ratio was higher in patients with polymyalgia rheumatica than in controls (p less than 0.001). On the contrary, circulating B cells were not altered. The decrease in peripheral blood OKT3+ and OKT8+ lymphocyte subsets suggests that there is an impairment of cell-mediated immunity in polymyalgia rheumatica.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335865

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  A seasonal pattern in the onset of polymyalgia rheumatica.

Authors:  M A Cimmino; R Caporali; C M Montecucco; S Rovida; E Baratelli; M Broggini
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.

Authors:  R Andersson; R Jonsson; A Tarkowski; B A Bengtsson; B E Malmvall
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

3.  Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

Authors:  A Uddhammar; G Roos; B Näsman; S R Dahlqvist
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

4.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G S Panayi
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

5.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G D Pountain; M T Keogan; D L Brown; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

6.  The Cambridge dilemma.

Authors:  P Elling; H Elling; A T Olsson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

7.  HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.

Authors:  R Andersson; G K Hansson; T Söderström; R Jonsson; B A Bengtsson; E Nordborg
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.